| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director, 10% Owner | Director
36 companies
Orbimed Advisors LLC is a Director, 10% Owner at EWTX with holdings across 36 companies. Recent SEC Form 4 filings include 6 buys and 21 sells.
Estimated insider holdings value: $2043.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 14, 2018 | Director | Sell | 10,300 | $13.50 | $139,050.00 | -0.2% | ||
| May 7, 2018 | INSP Inspire Medical Systems, Inc. | 10% Owner | Buy | 312,500 | $16.00 | $5,000,000.00 | +14.7% | |
| Apr 30, 2018 | PVLA Palvella Therapeutics, Inc. | 10% Owner, See Remarks | Sell | 1,000,000 | $6.35 | $6,350,000.00 | -18.0% | |
| Mar 29, 2018 | Director | Sell | 1,048,067 | $11.50 | $12,053,729.99 | -9.3% | ||
| Mar 12, 2018 | CRVS Corvus Pharmaceuticals, Inc. | Director, 10% Owner | Buy | 588,235 | $8.50 | $4,999,997.50 | +10.9% | |
| Mar 6, 2018 | GKOS Glaukos Corp | Director | Sell | 836,500 | $32.02 | $26,787,191.74 | -36.4% | |
| Feb 14, 2018 | XTNT Xtant Medical Holdings, Inc. | Director, 10% Owner | Buy | 945,819 | $7.20 | $6,809,896.80 | +11.4% | |
| Feb 13, 2018 | PVLA Palvella Therapeutics, Inc. | 10% Owner | Sale+OE | 7,897 | $8.98 | $70,915.06 | -0.1% | |
| Feb 8, 2018 | KALA Kala Bio, Inc. | 10% Owner | Buy | 25,000 | $12.93 | $323,250.00 | +0.7% | |
| Feb 2, 2018 | KALA Kala Bio, Inc. | 10% Owner | Buy | 37,840 | $14.73 | $557,383.20 | +1.1% |